David S. Goldstein

46.0k total citations · 8 hit papers
484 papers, 30.6k citations indexed

About

David S. Goldstein is a scholar working on Cardiology and Cardiovascular Medicine, Neurology and Surgery. According to data from OpenAlex, David S. Goldstein has authored 484 papers receiving a total of 30.6k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Cardiology and Cardiovascular Medicine, 144 papers in Neurology and 119 papers in Surgery. Recurrent topics in David S. Goldstein's work include Parkinson's Disease Mechanisms and Treatments (111 papers), Heart Rate Variability and Autonomic Control (105 papers) and Cardiovascular Syncope and Autonomic Disorders (83 papers). David S. Goldstein is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (111 papers), Heart Rate Variability and Autonomic Control (105 papers) and Cardiovascular Syncope and Autonomic Disorders (83 papers). David S. Goldstein collaborates with scholars based in United States, Israel and Netherlands. David S. Goldstein's co-authors include Irwin J. Kopin, Graeme Eisenhofer, Courtney Holmes, Yehonatan Sharabi, Harry R. Keiser, Karel Pacák, Jacques W.M. Lenders, Robin Stull, McClellan M. Walther and W. Marston Linehan and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David S. Goldstein

469 papers receiving 29.5k citations

Hit Papers

Biochemical Diagnosis of ... 1981 2026 1996 2011 2002 2004 2011 2010 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Biochemical Diagnosis of Pheochromocytoma
    2002 792 citations Karel Pacák, David S. Goldstein et al. profile →
  2. Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
    2004 756 citations Graeme Eisenhofer, Irwin J. Kopin et al. profile →
  3. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes
    2011 643 citations David S. Goldstein, Yehonatan Sharabi et al. profile →
  4. Detection of Water in the LCROSS Ejecta Plume
    2010 634 citations David S. Goldstein et al. profile →
  5. Takotsubo Cardiomyopathy
    2008 551 citations David S. Goldstein et al. profile →
  6. Plasma catecholamines and essential hypertension. An analytical review.
    1983 473 citations David S. Goldstein Hypertension profile →
  7. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
    1986 453 citations Graeme Eisenhofer, David S. Goldstein et al. Clinical Chemistry profile →
  8. II. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man
    1981 427 citations David S. Goldstein, Irwin J. Kopin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David S. Goldstein 8.2k 7.8k 6.7k 4.9k 4.8k 484 30.6k
Monique M.B. Breteler 10.8k 1.3× 3.9k 0.5× 14.2k 2.1× 4.8k 1.0× 4.3k 0.9× 485 66.9k
Irwin J. Kopin 4.4k 0.5× 2.7k 0.4× 6.6k 1.0× 12.6k 2.6× 2.4k 0.5× 531 32.4k
Graeme Eisenhofer 5.0k 0.6× 15.7k 2.0× 3.4k 0.5× 2.0k 0.4× 13.7k 2.9× 486 28.0k
Lenore J. Launer 7.5k 0.9× 2.5k 0.3× 5.8k 0.9× 1.8k 0.4× 3.4k 0.7× 612 43.4k
Costantino Iadecola 6.4k 0.8× 1.7k 0.2× 8.6k 1.3× 7.5k 1.5× 1.3k 0.3× 420 52.3k
Cornelia M. van Duijn 3.1k 0.4× 2.1k 0.3× 4.7k 0.7× 3.1k 0.6× 3.5k 0.7× 676 40.3k
Paul L. Huang 6.1k 0.7× 3.5k 0.4× 1.3k 0.2× 3.4k 0.7× 2.4k 0.5× 260 31.0k
Kazuwa Nakao 16.8k 2.0× 6.2k 0.8× 892 0.1× 3.5k 0.7× 6.2k 1.3× 863 50.3k
Friedrich C. Luft 16.9k 2.1× 6.8k 0.9× 690 0.1× 1.8k 0.4× 9.1k 1.9× 1.1k 50.6k
Michael A. Moskowitz 2.6k 0.3× 2.1k 0.3× 4.4k 0.7× 7.6k 1.6× 1.3k 0.3× 230 35.7k

Countries citing papers authored by David S. Goldstein

Since Specialization
Citations

This map shows the geographic impact of David S. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Goldstein more than expected).

Fields of papers citing papers by David S. Goldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Goldstein. The network helps show where David S. Goldstein may publish in the future.

Co-authorship network of co-authors of David S. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Goldstein. A scholar is included among the top collaborators of David S. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Goldstein. David S. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennedy, Benjamin C., et al.. (2025). Intravenous AAV9- ATP7A plus subcutaneous copper histidinate optimizes outcomes in a lethal Menkes disease mouse model. Science Advances. 11(35). eadw5612–eadw5612.
2.
Goldstein, David S.. (2025). Peripheral catecholamine systems: an evolutionary perspective. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 329(6). R1032–R1052.
3.
Parveen, Sabiha, Parvez Alam, Christina D. Orrú, et al.. (2025). A same day α-synuclein RT-QuIC seed amplification assay for synucleinopathy biospecimens. PubMed. 2(1). 8–8. 4 indexed citations
4.
Isonaka, Risa, Patti Sullivan, & David S. Goldstein. (2025). Pathophysiological Significance of α-Synuclein in Sympathetic Nerves. Neurology. 104(3). e210215–e210215. 2 indexed citations
5.
Heiss, John D., Abhik Ray‐Chaudhury, David E. Kleiner, et al.. (2024). Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2‐GDNF in a Patient with Parkinson's Disease. Movement Disorders. 39(8). 1412–1417. 10 indexed citations
6.
Enose‐Akahata, Yoshimi, Dima A. Hammoud, Sandeep Narpala, et al.. (2023). Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurology Neuroimmunology & Neuroinflammation. 10(4). 28 indexed citations
7.
Jayanthi, Subramaniam, Bruce Ladenheim, Patricia Sullivan, et al.. (2022). Biochemical Neuroadaptations in the Rat Striatal Dopaminergic System after Prolonged Exposure to Methamphetamine Self-Administration. International Journal of Molecular Sciences. 23(17). 10092–10092. 11 indexed citations
8.
Daiwile, Atul P., Patricia Sullivan, Subramaniam Jayanthi, David S. Goldstein, & Jean Lud Cadet. (2022). Sex-Specific Alterations in Dopamine Metabolism in the Brain after Methamphetamine Self-Administration. International Journal of Molecular Sciences. 23(8). 4353–4353. 13 indexed citations
9.
Sullivan, Patti, et al.. (2021). The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease. Disease Models & Mechanisms. 15(1). 18 indexed citations
10.
Xu, Mafei, Shih‐Chieh Lin, Hui-Ju Lee, et al.. (2020). Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson’s disease through mitochondrial dysfunction. PLoS Genetics. 16(6). e1008868–e1008868. 16 indexed citations
11.
Goldstein, David S.. (2017). Autonomous Vehicles Will Drive Themselves – But They Won’t Regulate Themselves. 13(2). 241.
12.
Goldstein, David S., Courtney Holmes, Patti Sullivan, et al.. (2015). Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. Parkinsonism & Related Disorders. 21(9). 1013–1022. 27 indexed citations
13.
Demetri, George D., Patrick Schöffski, Manisha H. Shah, et al.. (2012). Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure. Clinical Cancer Research. 18(11). 3170–3179. 102 indexed citations
14.
Wang, Yu, Aneeka M. Hancock, Joshua M. Bradner, et al.. (2011). Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy. American Journal Of Pathology. 178(4). 1509–1516. 96 indexed citations
15.
Goldstein, David S. & Courtney Holmes. (2008). Neuronal Source of Plasma Dopamine. Clinical Chemistry. 54(11). 1864–1871. 74 indexed citations
16.
Gold, Philip W., Ma‐Li Wong, David S. Goldstein, et al.. (2005). Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proceedings of the National Academy of Sciences. 102(23). 8303–8308. 76 indexed citations
17.
Goldstein, David S., Sandra Pechnik, Courtney Holmes, Basil A. Eldadah, & Yehonatan Sharabi. (2003). Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic Failure. Hypertension. 42(2). 136–142. 177 indexed citations
18.
Nagatsu, T, et al.. (2002). Catecholamine research : from molecular insights to clinical medicine. 24 indexed citations
19.
Goldstein, David S., Graeme Eisenhofer, & Richard McCarty. (1998). Catecholamines : bridging basic science with clinical medicine. Data Archiving and Networked Services (DANS). 61 indexed citations
20.
Cizza, Giovanni, Karel Pacák, Richard Květňanský, et al.. (1995). Decreased stress responsivity of central and peripheral catecholaminergic systems in aged 344/N Fischer rats.. Journal of Clinical Investigation. 95(3). 1217–1224. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique M.B. Breteler Breakdown of academic impact, for papers by Irwin J. Kopin Breakdown of academic impact, for papers by Graeme Eisenhofer Breakdown of academic impact, for papers by Lenore J. Launer Breakdown of academic impact, for papers by Costantino Iadecola Breakdown of academic impact, for papers by Cornelia M. van Duijn Breakdown of academic impact, for papers by Paul L. Huang Breakdown of academic impact, for papers by Kazuwa Nakao Breakdown of academic impact, for papers by Friedrich C. Luft Breakdown of academic impact, for papers by Michael A. Moskowitz
Rankless by CCL
2026